Product
Ipratropium / Levosalbutamol
1 clinical trial
1 indication
Indication
Chronic Obstructive Pulmonary DiseaseClinical trial
A Randomized, Parallel Group, Phase III, Non-inferiority Study Comparing Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions in Stable Chronic Obstructive Pulmonary Disease (COPD)Status: Recruiting, Estimated PCD: 2024-02-06